Botanix Pharmaceuticals Limited
BXPHF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 178.2% | -45.1% | 36.9% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 40.3% | -76.5% | -80.7% | -273.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,427.1% | -666.2% | -237.6% | -471.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,500.6% | -670.2% | -242.7% | -478.1% |
| EPS Diluted | -0.047 | -0.009 | -0.008 | -0.014 |
| % Growth | -408.7% | -16.5% | 41.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |